Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Tumori|February 24, 2001
Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literatureL Moscetti, R Saltarelli, R Giuliani, et al.Tumori|October 24, 2001
Response of metastatic epidermoid anal cancer to single agent irinotecan: a case reportF Grifaichi, A Padovani, F Romeo, et al.Current Cancer Drug Targets|April 14, 2010
Circulating tumor cells in cancer therapy: are we off target?C Raimondi, G Naso, A Gradilone, et al.Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1983
Dose-response studies on neoplastic transformation of BALB/3T3 clone A31-1-1 cells by aflatoxin B1, benzidine, benzo[a]pyrene, 3-methylcholanthrene, and N-methyl-N'-nitro-N-nitrosoguanidineE Cortesi, U Saffiotti, P J Donovan, et al.Toxicologic Pathology|January 1, 1984
Studies on chemically induced neoplastic transformation and mutation in the BALB/3T3 Cl A31-1-1 cell line in relation to the quantitative evaluation of carcinogensU Saffiotti, M Bignami, F Bertolero, et al.Minerva Chirurgica|May 15, 1992
[Clinical use of a totally implantable and programmable pump for the infusion of drugs]N Balletto, M Cavallini, E Cortesi, et al.Current Medicinal Chemistry|June 12, 2012
Molecular and clinical analysis of predictive biomarkers in non-small-cell lung cancerA Passaro, A Palazzo, P Trenta, et al.Prostate Cancer and Prostatic Diseases|July 31, 2013
Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trialsR Iacovelli, A Altavilla, G Procopio, et al.La Radiologia Medica|January 22, 2010
Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastasesR Cianni, C Urigo, E Notarianni, et al.European Radiology|July 28, 2012
Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancerR Cianni, G Pelle, E Notarianni, et al.Pageof 8